Autolus Therapeutics PLC (NAS:AUTL)
$ 3.82 -0.02 (-0.52%) Market Cap: 1.01 Bil Enterprise Value: 314.39 Mil PE Ratio: 0 PB Ratio: 1.74 GF Score: 55/100

Autolus Therapeutics PLC at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 01:00AM GMT
Release Date Price: $12.85 (+1.02%)
Jackson Lowrie;JPMorgan;Investment Banking Associate

Good afternoon. My name is Jackson Lowrie, and I'm a member of the JPMorgan health care investment banking team. Welcome today, and it's my pleasure to introduce our next speaker, Christian Itin, from -- the CEO of Autolus. And just before I let Christian come up here, afterwards, we'll be having a breakout session in the Yorkshire room, which is just outside and then to the left. So now I'll hand over to Christian.

Christian Martin Itin
Autolus Therapeutics plc - Chairman & CEO

Well, thank you very much. Thank you very much for the invitation. Thanks to all of you for joining us at a late afternoon on day 3 of the JPMorgan conference. I salute your stamina. And I'm looking forward to, obviously, sharing with you what we believe will be an exciting year for the company.

Obviously, we're a publicly listed company, so please have a look at our SEC filings for the risk factors of the business.

We are currently active in a number of clinical programs. We have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot